meRfi®-GM
Filgrastim-sndz, & Approvals
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
To decrease the incidence of infection‘ as manifested by febrile neutropenia‘ in patients with nonmyeloid malignancies receiving myelosuppressive anticancer drugs associated with a significant incidence of severe neutropenia with fever
Nahleh et al. 2022 JCO Oncol Pract 18: 177-186
To reduce the time to neutrophil recovery and the duration of fever, after induction or consolidation chemotherapy treatment of patients with AML
Nahleh et al. 2022 JCO Oncol Pract 18: 177-186
To reduce the duration of neutropenia and neutropenia-related clinical sequelae‘ eg‘ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by BMT
Nahleh et al. 2022 JCO Oncol Pract 18: 177-186
To mobilize autologous hematopoietic progenitor cells into the peripheral blood for collect…